APA

Senses K. M., Ghasemi M., Akbar M. W., Isbilen M., Fallacara A. L., Frankenburg S., Schenone S., Lotem M., Botta M. & Gure A. O. (2017). Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma. : MedChemComm.

Chicago

Senses Kerem M, Ghasemi Mehdi, Akbar Muhammad W, Isbilen Murat, Fallacara Anna L, Frankenburg Shoshana, Schenone Silvia, Lotem Michal, Botta Maurizio and Gure Ali O. 2017. Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma. : MedChemComm.

Harvard

Senses K. M., Ghasemi M., Akbar M. W., Isbilen M., Fallacara A. L., Frankenburg S., Schenone S., Lotem M., Botta M. and Gure A. O. (2017). Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma. : MedChemComm.

MLA

Senses Kerem M, Ghasemi Mehdi, Akbar Muhammad W, Isbilen Murat, Fallacara Anna L, Frankenburg Shoshana, Schenone Silvia, Lotem Michal, Botta Maurizio and Gure Ali O. Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma. : MedChemComm. 2017.